Promation Ltd.

About Promation Ltd.

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• PR Newswire · 2026-06-15
  Promation Ltd announces Phase II readout for lead theranostic candidate
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• Nuclear Medicine Today · 2026-05-20
  Promation Ltd expands cyclotron capacity to meet Lu-177 demand
  Coverage notes the company's growing footprint in the radioligand therapy space.
• STAT News · 2026-08-13
  Promation Ltd signs supply agreement to support late-stage trials
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• Imaging Wire · 2026-03-22
  Promation Ltd appoints new Chief Medical Officer ahead of pivotal trial
  The work builds on more than a decade of radiochemistry collaboration.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.